Loading provider…
Loading provider…
Cardiovascular Disease Physician in San Diego, CA
NPI: 1508912387Primary Practice Location
UCSD Hillcrest Medical Center
200 W Arbor Dr, San Diego, California, 92103
HQ Phone
Get MD Ori's Phone NumberMobile
Get MD Ori's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1993 - 2026
NY State Medical License
1993 - 2024

American Board of Internal Medicine
Cardiovascular Disease
University of California (San Diego) Medical Center
health.ucsd.edu
Fellowship • Cardiovascular Disease
1993 - 1996
NYU Grossman School of Medicine
med.nyu.edu
Residency • Internal Medicine
1990 - 1993
Tel Aviv University Sackler
tau.ac.il
Medical School
Until 1985
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 98 | 158 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 87 | 136 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 66 | 177 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 57 | 58 |
| 5 | 99238Hospital discharge day management, 30 minutes or less | 28 | 29 |
Does hysteroscopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasia or carcinoma?
Authors: Ben-Yehuda, O. M., Kim, Y. B., Leuchter, R. S.
Safety and Efficacy of Ezetimibe Added to Atorvastatin Versus Up Titration of Atorvastatin to 40 mg in Patients ≥65 Years of Age (from the ZETia in the ELDerly [ZETELD] Study)
Authors: Franklin J. Zieve, Nanette K. Wenger, Ori Ben-Yehuda, Christian Constance, Steven R. Bird, Raymond Lee, Mary E. Hanson, Charlotte Jones-Burton, Andrew M. Tershakovec
Publication Date: 2010-03
Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial.
Authors: Shmuel Chen, John Puskas
Publication Date: 2018-04-17
Lead Sponsor: University of California, San Diego
Collaborators: Merck Sharp & Dohme LLC
Intervention / Treatment: DRUG: Atorvastatin, DRUG: Ezetimibe
Lead Sponsor: University of California, San Diego
Intervention / Treatment: DRUG: ranolazine
Lead Sponsor: University of California, San Diego
Intervention / Treatment: DRUG: Ezetimibe